OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
February 21, 2024
Challenges in fermentation can be addressed through equipment changes, facility design, and process development.
AstraZeneca has completed its acquisition of Icosavax, gaining the IVX-A12 vaccine candidate that targets RSV and hMPV.
GSK is expanding its respiratory biologics portfolio with its acquisition of Aiolos Bio and its novel therapy, AIO-001.
February 20, 2024
FDA has approved Iovance Biotherapeutics’ Amtagvi (lifileucel) for treating patients with unresectable or metastatic melanoma.
February 17, 2024
Steffen Thirstrup, chief medical officer at the European Medicines Agency, provides insight on regulatory challenges in Europe.
February 16, 2024
In surplus and shortage, compounding amplifies all.
Two public electronic catalogues will be available for real-world data sources and for real-world data studies.
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
Managing the intricacies of sterile product development is imperative for successful and compliant outcomes.
The need for preclinical testing expertise is growing as molecular complexity increases.